| Ticker | Company | Zen Rating | Financials | Market Cap | ROE | ROA | ROCE | ROIC | D/E | Current Ratio | Gross Margin | Profit Margin | Operating Margin |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| PGEN | PRECIGEN INC | $1.54B | 57.90% | 14.40% | 20.09% | 18.00% | 1.53 | 5.58 | 91.40% | 15.60% | 23.21% | ||
| CORT | CORCEPT THERAPEUTICS INC | $7.67B | 22.60% | 17.80% | 12.61% | 17.10% | 0.24 | 3.01 | 98.50% | 16.50% | 11.20% | ||
| FENC | FENNEC PHARMACEUTICALS INC | $479.44M | 4.90% | 2.70% | 4.02% | 12.70% | 0.70 | 6.11 | 94.10% | 3.10% | 4.26% | ||
| TGTX | TG THERAPEUTICS INC | $9.48B | 17.60% | 7.30% | 14.73% | 13.00% | 1.78 | 4.50 | 82.70% | 11.80% | 21.85% | ||
| LGND | LIGAND PHARMACEUTICALS INC | $5.88B | 5.20% | 2.70% | 3.51% | 3.40% | 1.33 | 1.22 | 95.20% | 20.30% | 24.00% | ||
| ARQT | ARCUTIS BIOTHERAPEUTICS INC | $3.46B | 14.20% | 6.30% | 12.65% | 11.60% | 1.15 | 2.92 | 91.20% | 5.90% | 8.76% | ||
| RPRX | ROYALTY PHARMA PLC | $39.40B | 6.80% | 3.40% | 5.71% | 4.00% | 0.99 | 1.29 | 100.00% | 25.70% | 39.88% | ||
| KRYS | KRYSTAL BIOTECH INC | $8.85B | 17.00% | 15.50% | 17.92% | 29.70% | 0.11 | 7.89 | 94.30% | 47.90% | 55.06% | ||
| KNSA | KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | $7.47B | 17.30% | 12.60% | 18.47% | 26.90% | 0.38 | 3.91 | 90.20% | 11.60% | 15.45% | ||
| HALO | HALOZYME THERAPEUTICS INC | $10.94B | 544.30% | 17.30% | 22.59% | 22.80% | -63.88 | 3.88 | 82.30% | 26.90% | 37.56% | ||
| JAZZ | JAZZ PHARMACEUTICALS PLC | $15.45B | 4.60% | 1.80% | 4.52% | 6.30% | 1.86 | 1.82 | 89.10% | 4.40% | 9.06% | ||
| ADMA | ADMA BIOLOGICS INC | $3.02B | 42.60% | 27.00% | 38.47% | 38.40% | 0.67 | 6.04 | 68.50% | 35.10% | 47.22% | ||
| VCEL | VERICEL CORP | $2.95B | 9.10% | 6.70% | 7.53% | 8.30% | 0.35 | 5.13 | 74.50% | 10.30% | 10.74% | ||
| TECH | BIO-TECHNE CORP | $11.41B | 8.20% | 6.70% | 10.42% | 20.90% | 0.22 | 2.28 | 65.80% | 14.00% | 19.30% | ||
| ZVRA | ZEVRA THERAPEUTICS INC | $559.34M | 38.20% | 26.50% | 34.40% | 62.20% | 0.31 | 5.46 | 95.40% | 52.80% | 63.37% | ||
| VRTX | VERTEX PHARMACEUTICALS INC | $135.44B | 20.10% | 14.20% | 17.30% | 27.10% | 0.57 | 2.34 | 85.50% | 30.70% | 37.05% | ||
| INCY | INCYTE CORP | $24.27B | 7.10% | 5.50% | 13.65% | 35.30% | 0.29 | 3.84 | 92.70% | 6.70% | 13.29% | ||
| EXEL | EXELIXIS INC | $16.71B | 45.50% | 33.90% | 50.72% | 53.20% | 0.37 | 3.21 | 96.30% | 35.50% | 42.69% | ||
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | $1.94B | 18.50% | 13.20% | 20.38% | 45.00% | 0.38 | 3.44 | 74.00% | 18.10% | 24.85% | ||
| REGN | REGENERON PHARMACEUTICALS INC | $99.08B | 15.10% | 11.50% | 15.01% | 16.40% | 0.33 | 3.35 | 85.80% | 28.50% | 33.93% | ||
| UTHR | UNITED THERAPEUTICS CORP | $24.88B | 19.20% | 17.10% | 23.71% | 30.10% | 0.12 | 4.61 | 86.30% | 38.60% | 47.68% | ||
| CYPH | CYPHERPUNK TECHNOLOGIES INC | $205.29M | -0.90% | -0.90% | 0.89% | 1.40% | 0.03 | 79.19 | N/A | N/A | N/A | ||
| VCYT | VERACYTE INC | $1.96B | 9.30% | 8.60% | 7.94% | 44.30% | 0.10 | 5.56 | 72.00% | 21.80% | 20.33% |